Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective
Year: 2020
Type: article
Abstract: At the end of 2019, a novel severe acute respiratory syndrome (SARS) coronavirus (CoV), named SARS-CoV-2 or 2019-nCoV, has been identified as the microbial agent causing viral pneumonia in several patients epidemiologically linked to a seafood market in Wuhan (Hubei province, China).1 2 Since then, the spread of coronavirus disease 2019 (COVID-19) has progressively involved countries outside China leading the World Health Organization (WHO) to make the assessment that COVID-19 can be characterised as a pandemic.
Source: ESMO Open
Institutions: Ospedale Policlinico San Martino, University of Genoa, Azienda Ospedaliero-Universitaria di Modena, European Institute of Oncology, University of Pisa, University of Campania "Luigi Vanvitelli", Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Istituto Oncologico Veneto, Fondazione IRCCS Istituto Nazionale dei Tumori, Azienda Ospedaliero-Universitaria Careggi, University of Florence, University of Padua, Azienda Ospedaliera Sant'Andrea, University of Turin
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,910
OpenAlex ID: W3013284119
